Reports on more recent large studies of HR-NB do not include patients with MYCN-amplified stage 2/3 [20, 39], have few such patients (n=6 [40], n=4 [41]), or do not separate out the results in this subset [11, 16]. The gene discussed is MYCN; the disease is neuroblastoma.